Alfredo García Layana-rekin lankidetzan egindako argitalpenak (11)

2024

  1. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

    Ophthalmology, Vol. 131, Núm. 6, pp. 708-723

2023

  1. Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial

    Japanese Journal of Ophthalmology, Vol. 67, Núm. 3, pp. 264-279

2022

  1. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

    The Lancet, Vol. 399, Núm. 10326, pp. 741-755

2021

  1. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?

    Journal of Internal Medicine, Vol. 289, Núm. 1, pp. 116-120

2012

  1. Optimization of 100 μm alginate-poly-l-lysine-alginate capsules for intravitreous administration

    Journal of Controlled Release, Vol. 158, Núm. 3, pp. 443-450

2000

  1. Optical coherence tomography evaluation of the corneal cap and stromal bed features after laser in situ keratomileusis for high myopia and astigmatism

    Ophthalmology, Vol. 107, Núm. 1, pp. 81-87

1999

  1. Final clear corneal incision size for AcrySof intraocular lenses

    Journal of Cataract and Refractive Surgery, Vol. 25, Núm. 7, pp. 959-963

1998

  1. Optical coherence tomography in successful surgery of vitreomacular traction syndrome

    Archives of Ophthalmology, Vol. 116, Núm. 10, pp. 1388-1389

  2. Variation in clear cornea incision size after phacoemulsification and foldable lens implantation

    Journal of Cataract and Refractive Surgery, Vol. 24, Núm. 7, pp. 931-934

1996

  1. Autofluorescence and ultrastructural analysis of lipofuscin accumulation in porcine retinal pigment epithelium and fatty acid diet

    Investigative Ophthalmology and Visual Science, Vol. 37, Núm. 3

  2. The amount of lens exfoliation and chamber-angle pigmentation in exfoliative syndrome with or without glaucoma.

    Acta ophthalmologica Scandinavica